Literature DB >> 29532918

Low dose PD-1 inhibition in relapsed refractory Hodgkin lymphoma after allogeneic stem cell transplant with concomitant active GVHD.

Adrian Minson1, Genevieve Douglas1, Ian Bilmon2, Andrew Grigg1.   

Abstract

Entities:  

Keywords:  zzm321990GVHDzzm321990; Hodgkin lymphoma; immunotherapy; stem cell transplantation

Mesh：

Substances：

Year:  2018        PMID： 29532918     DOI： 10.1111/bjh.15186

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Case Report: Preemptive Treatment With Low-Dose PD-1 Blockade and Azacitidine for Molecular Relapsed Acute Myeloid Leukemia With RUNX1-RUNX1T1 After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Yutong Tang; Zhenyang Zhou; Han Yan; Yong You
Journal:  Front Immunol       Date:  2022-02-02       Impact factor: 7.561

Review 2.  Post-hematopoietic stem cell transplantation relapse: Role of checkpoint inhibitors.

Authors:  Elham Roshandel; Farzaneh Tavakoli; Sayeh Parkhideh; Sedigheh Sadat Akhlaghi; Maria Tavakoli Ardakani; Masoud Soleimani
Journal:  Health Sci Rep       Date:  2022-03-08

Review 3.  Dosing Regimens of Immune Checkpoint Inhibitors: Attempts at Lower Dose, Less Frequency, Shorter Course.

Authors:  Mengjie Jiang; Yujie Hu; Gang Lin; Chao Chen
Journal:  Front Oncol       Date:  2022-06-20       Impact factor: 5.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.